Emmforce Auto. (544166)

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Revenue growth of 52.84% shows strong demand traction.
• Piotroski F-Score of 7/9 indicates healthy fundamentals across profitability, leverage and efficiency.
• ROCE of 16.02% suggests decent capital efficiency.
• PEG of 0.82 implies the growth is not excessively priced relative to earnings multiple.
• Trading near the 52-week high reflects positive market sentiment.

Concerns

• Profit growth of 19.82% lags sales growth of 52.84%, pointing to margin compression.
• Net margin is thin at roughly 7.4% (₹4 Cr profit on ₹54 Cr sales).
• No dividend and a P/E of 29.89 leave little support if growth slows.
• Critical data such as book value, ROE, debt/equity and promoter holding are missing, making balance-sheet risk hard to assess.

AI Analysis

At first glance, Emmforce Auto appears to be an interesting small-cap compounder, but Graham would demand I look behind the curtain. The company is growing sales at 52.84%, and at ₹166.25, the market capitalisation is only ₹349 Cr. That is a rapid pace, and with a PEG of 0.82, the market is paying less for growth than the raw P/E of 29.89 suggests. However, profit growth of 19.82% trails revenue growth significantly. That tells me margins are being squeezed, perhaps due to input costs or competitive pressure. If I am buying a growth story, I want earnings to at least keep pace with sales. The Piotroski F-Score of 7/9 is encouraging; it signals solid fundamentals across profitability, leverage and efficiency. ROCE of 16.02% is respectable and suggests management is creating value from capital employed. But I notice the data is incomplete: no book value, no ROE, no debt-to-equity, and no promoter holding. As an investor, I cannot fully assess financial risk without knowing leverage or insider ownership. The latest quarter shows sales of ₹54 Cr and net profit of ₹4 Cr, a 7.4% net margin. That is not terrible for auto components, but it is thin. The company pays no dividend, so my return depends entirely on future growth and eventual valuation. Buying near the 52-week high of ₹168.92 leaves little margin of safety. I would need to watch whether margins stabilise, debt levels remain low, and the promoter stays aligned. At 30 times earnings, any stumble in the growth story could hit the stock hard. A high-quality grower can justify a rich multiple, but I need more transparency before calling this a true Buffett-style bargain.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer